Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation

Journal of Surgical Research

Volumn 90, Issue 2, 2000, Pages 119-125

  Chen, Raymond H ^a   Kadner, Alexander ^a   Mitchell, Richard N ^a   Adams, David H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Gal; Heart; Pathology; Pig; Xenotransplantation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 0034657755     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5864     Document Type: Article

References (36)

1. Gao F., Bailes E., Robertson D. L. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes [see comments]. Nature. 397:1999;436.
2. Kaplon R. J., Platt J. L., Kwiatkowski P. A. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation. 59:1995;410.
3. Larsen R. D., Rivera-Marrero C. A., Ernst L. K., Cummings R. D., Lowe J. B. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-d-Gal(1,4)-d-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J. Biol. Chem. 265:1990;7055.
4. Adams D. H., Chen R. H., Naficy S., Kadner A. Technique for heterotopic pig heart xenotransplantation in primates. Ann. Thorac. Surg. 68:1999;265.
5. Platt J. L., Fischel R. J., Matas A. J., Reif S. A., Bolman R. M., Bach F. H. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation. 52:1991;214.
6. Sandrin M., Vaughan H., Dabkowski P., Mcenzie I. Anti-pig IgM antibodies in human serum react predominantly with Gal (alpha 1,3) epitopes. Proc. Natl. Acad. Sci. USA. 90:1993;11391.
7. Galili U., Clark M. R., Shohet S. B., Buehler J., Macher B. A. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates. Proc. Natl. Acad. Sci. USA. 84:1987;1369.
8. Leventhal J. R., Dalmasso A. P., Cromwell J. W. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation. 55:1993;857.
9. Leventhal J. R., John R., Fryer J. P. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies. Transplantation. 59:1995;294.
10. Saadi S., Platt J. L. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J. Exp. Med. 181:1995;21.
11. Platt J. L., Dalmasso A. P., Vercellotti G. M., Lindman B. J., Turman M. A., Bach F. H. Endothelial cell proteoglycans in xenotransplantation. Transplant. Proc. 22:1990;1066.
12. Adams E. M., Brown M. C., Nunge M., Krych M., Atkinson J. P. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147:1991;3005.
13. Ballard L., Seya T., Teckman J., Lublin D. M., Atkinson J. P. A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). J. Immunol. 138:1987;3850.
14. Brooimans R. A., Van der Ark A. A., Tomita M., Van Es L. A., Daha M. R. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Eur. J. Immunol. 22:1992;791.
15. Brooimans R. A., van Wieringen P. A., van Es L. A., Daha M. R. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur. J. Immunol. 22:1992;3135.
16. Davies A., Lachmann P. J. Membrane defence against complement lysis: The structure and biological properties of CD59. Immunol. Res. 12:1993;258.
17. Hamilton K. K., Ji Z., Rollins S., Stewart B. H., Sims P. J. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: Neutralization of a C5b-9 inhibitor by antibody to CD59. Blood. 76:1990;2572.
18. Hansch G., Hammer G., Vanguri P., Shin M. Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc. Natl. Acad. Sci. USA. 78:1981;5118.
19. Hansch G. M., Hammer C. H., Vanguri P., Shin M. L. Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc. Natl. Acad. Sci. USA. 78:1981;5118.
20. Rollins S. A., Zhao J., Ninomiya H., Sims P. J. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146:1991;2345.
21. Shin M. L., Hansch G., Hu V. W., Nicholson-Weller A. Membrane factors responsible for homologous species restriction of complement-mediated lysis: Evidence for a factor other than DAF operating at the stage of C8 and C9. J. Immunol. 136:1986;1777.
22. Lachmann P. J. The control of homologous lysis. Immunol. Today. 12:1991;312.
23. Diamond L. E., McCurry K. R., Martin M. J. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation. 61:1996;1241.
24. Chen R. H., Naficy S., Logan J. S., Diamond L. E., Adams D. H. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation. 6:1999;122.
25. Platt J. L., Lin S. S., McGregor C. G. Acute vascular rejection. Xenotransplantation. 5:1998;169.
26. Bach F. H., Winkler H., Ferran C., Hancock W. W., Robson S. C. Delayed xenograft rejection. Immunol. Today. 17:1996;379.
27. Logan J., Martin M. Transgenic swine as a recombinant production for human hemoglobulin. Methods Enzymol. 231:1994;435.
28. Alroy J., Goyal V., Skutelsky E. Lectin histochemistry of mammalian endothelium. Histochemistry. 86:1987;603.
29. Chen R. H., Mitchell R. N., Kadner A., Adams D. H. Differential galactose α(1,3) galactose expression by porcine cardiac vascular endothelium. Xenotransplantation. 6:1999;169.
30. Oriol R., Ye Y., Koren E., Cooper D. K. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation. 56:1993;1433.
31. LaVecchio J. A., Dunne A. D., Edge A. S. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation. 60:1995;841.
32. Saadi, S, Holzknecht, R. A, Patte, C. P, Stern, D. M, and, Platt, J. L. Complement-mediated regulation of tissue factor activity in endothelium, J. Exp. Med. 182, 1807, 1995.
33. Lawson J. H., Platt J. L. Molecular barriers to xenotransplantation. Transplantation. 62:1996;303.
34. Ikematsu H., Harindranath N., Ueki Y., Notkins A. L., Casali P. Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J. Immunol. 150:1993;1325.
35. Ikematsu H., Kasaian M. T., Schettino E. W., Casali P. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. J. Immunol. 151:1993;3604.
36. Ikematsu, H, Ichiyoshi, Y, Schettino, E. W, Nakamura, M, and, Casali, P. VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection, J. Immunol. 152, 1430, 1994.